Daniel Markowitz
Stock Analyst at Evercore ISI Group
(3.21)
# 1,103
Out of 5,015 analysts
14
Total ratings
58.33%
Success rate
3.18%
Average return
Main Sectors:
Stocks Rated by Daniel Markowitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Maintains: Outperform | $60 → $72 | $58.66 | +22.74% | 2 | Oct 7, 2025 | |
| RGEN Repligen | Maintains: Outperform | $155 → $175 | $145.24 | +20.49% | 4 | Oct 7, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $150 → $125 | $75.17 | +66.29% | 2 | Oct 7, 2025 | |
| GH Guardant Health | Maintains: Outperform | $60 → $68 | $64.22 | +5.89% | 1 | Oct 7, 2025 | |
| RMBS Rambus | Maintains: Outperform | $81 → $114 | $89.57 | +27.27% | 1 | Sep 16, 2025 | |
| TMDX TransMedics Group | Initiates: Outperform | $155 | $107.29 | +44.47% | 1 | Sep 16, 2025 | |
| NTRA Natera | Initiates: Outperform | $170 | $169.27 | +0.43% | 1 | Jul 28, 2025 | |
| WST West Pharmaceutical Services | Maintains: Outperform | $275 → $350 | $261.77 | +33.71% | 2 | Jul 25, 2025 |
Bio-Techne
Oct 7, 2025
Maintains: Outperform
Price Target: $60 → $72
Current: $58.66
Upside: +22.74%
Repligen
Oct 7, 2025
Maintains: Outperform
Price Target: $155 → $175
Current: $145.24
Upside: +20.49%
Inspire Medical Systems
Oct 7, 2025
Maintains: Outperform
Price Target: $150 → $125
Current: $75.17
Upside: +66.29%
Guardant Health
Oct 7, 2025
Maintains: Outperform
Price Target: $60 → $68
Current: $64.22
Upside: +5.89%
Rambus
Sep 16, 2025
Maintains: Outperform
Price Target: $81 → $114
Current: $89.57
Upside: +27.27%
TransMedics Group
Sep 16, 2025
Initiates: Outperform
Price Target: $155
Current: $107.29
Upside: +44.47%
Natera
Jul 28, 2025
Initiates: Outperform
Price Target: $170
Current: $169.27
Upside: +0.43%
West Pharmaceutical Services
Jul 25, 2025
Maintains: Outperform
Price Target: $275 → $350
Current: $261.77
Upside: +33.71%